Heterozygosity for Fibrinogen Results in Efficient Resolution of Kidney Ischemia Reperfusion Injury
Open Access
- 19 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e45628
Abstract
Fibrinogen (Fg) has been recognized to play a central role in coagulation, inflammation and tissue regeneration. Several studies have used Fg deficient mice (Fg−/−) in comparison with heterozygous mice (Fg+/−) to point the proinflammatory role of Fg in diverse pathological conditions and disease states. Although Fg+/− mice are considered ‘normal’, plasma Fg is reduced to ∼75% of the normal circulating levels present in wild type mice (Fg+/+). We report that this reduction in Fg protein production in the Fg+/− mice is enough to protect them from kidney ischemia reperfusion injury (IRI) as assessed by tubular injury, kidney dysfunction, necrosis, apoptosis and inflammatory immune cell infiltration. Mechanistically, we observed binding of Fg to ICAM-1 in kidney tissues of Fg+/+ mice at 24 h following IRI as compared to a complete absence of binding observed in the Fg+/− and Fg−/− mice. Raf-1 and ERK were highly activated as evident by significantly higher phosphorylation in the Fg+/+ kidneys at 24 h following IRI as compared to Fg+/− and Fg−/− mice kidneys. On the other hand Cyclin D1 and pRb, indicating higher cell proliferation, were significantly increased in the Fg+/− and Fg−/− as compared to Fg+/+ kidneys. These data suggest that Fg heterozygosity allows maintenance of a critical balance of Fg that enables regression of initial injury and promotes faster resolution of kidney damage.Keywords
This publication has 30 references indexed in Scilit:
- Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemiaJournal of Thrombosis and Haemostasis, 2006
- A fibrinogen deficiency accelerates the initiation of LDL cholesterol–driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed miceBlood, 2006
- Fibrinogen - marker or mediator of vascular disease?Vascular Medicine, 2003
- Genes Encoding Fibrinogen and Cardiovascular RiskHypertension, 2001
- Genetic Manipulation of Fibrinogen and Fibrinolysis in MiceAnnals of the New York Academy of Sciences, 2001
- Transcriptional Control Mechanism of Fibrinogen Gene ExpressionAnnals of the New York Academy of Sciences, 2001
- β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial InfarctionCirculation, 1996
- Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.Genes & Development, 1995
- Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- FIBRINOGEN AND FIBRINAnnual Review of Biochemistry, 1984